Abstract: . . .  Final Report for atrial fibrillation August 2005 Number of submissions: 2 Organisations that submitted: Department of Health . . .
. . .  treated with anticoagulant therapy or anti- platelet (unless a contra-indication or side effects are recorded) Appendix A Methodology This report was written by: Jonathan Mant, University of Birmingham. 3 Page 4 References r t t . . .
. . .  8 Hobbs FDR et al. A RCT and cost effectiveness s udy of systematic screening (targeted and total population screening) versus routine practice for the detec ion of atrial fibrillation in the over 65s: The SAFE study. In press, Health Technology Assessment 2005. 4  . . .
. . .  et al. A RCT and cost effectiveness s udy of systematic screening (targeted and total population screening) versus routine practice for the detec ion of atrial fibrillation in the over 65s: The SAFE study. In press, Health Technology Assessment 2005. 4  . . .
. . .  RCT and cost effectiveness s udy of systematic screening (targeted and total population screening) versus routine practice for the detec ion of atrial fibrillation in the over 65s: The SAFE study. In press, Health Technology Assessment 2005. 4  . . .
--1595,5,160,1710,7974